1. 246 Clinicopathologic and genomic correlates of tumor mutational burden and its impact on PD-(L)1 inhibition efficacy in non-small cell lung cancer according to different PD-L1 expression subgroups. (9th November 2020) Authors: Ricciuti, Biagio; Mahadevan, Navin; Umeton, Renato; Alessi, Joao; Polio, Andrew; Vokes, Natalie; Leonardi, Giulia; Aguilar, Elizabeth; Recondo, Gonzalo; Lamberti, Giuseppe; Lawrence, Marissa; Janne, Pasi; Allen, Eliezer Van; Sholl, Lynette; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 246 Clinicopathologic and genomic correlates of tumor mutational burden and its impact on PD-(L)1 inhibition efficacy in non-small cell lung cancer according to different PD-L1 expression subgroups. (10th December 2020) Authors: Ricciuti, Biagio; Mahadevan, Navin; Umeton, Renato; Alessi, Joao; Polio, Andrew; Vokes, Natalie; Leonardi, Giulia; Aguilar, Elizabeth; Recondo, Gonzalo; Lamberti, Giuseppe; Lawrence, Marissa; Janne, Pasi; Allen, Eliezer Van; Sholl, Lynette; Awad, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires. (24th May 2019) Authors: Recondo, Gonzalo; Cosacow, César; Cutuli, Hernán Javier; Cermignani, Luciano; Straminsky, Samanta; Naveira, Martin; Pitzzu, Martin; De Ronato, Gabriela; Nacuzzi, Gabriela; Taetti, Gonzalo; Corsico, Santiago; Berrueta, Mabel; Colucci, Giuliana; Gibbons, Luz; Gutierrez, Laura; García-Elorrio, Ezequiel Journal: International journal for quality in health care Issue: Volume 31:Number 9(2019) Page Start: 682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non‐small cell lung cancer (AB‐CLICaP). Issue 9 (24th July 2020) Authors: Ruiz‐Patiño, Alejandro; Barrón, Feliciano; Cardona, Andrés F.; Corrales, Luis; Mas, Luis; Martín, Claudio; Zatarain‐Barrón, Zyanya L.; Recondo, Gonzalo; Ricaurte, Luisa; Rojas, Leonardo; Archila, Pilar; Rodríguez, July; Sotelo, Carolina; Viola, Lucia; Vargas, Carlos; Carranza, Hernán; Otero, Jorg... Journal: Thoracic cancer Issue: Volume 11:Issue 9(2020) Page Start: 2552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Argentine consensus recommendations for lung cancer screening programmes: a RAND/UCLA-modified Delphi study. Issue 2 (3rd February 2023) Authors: Boyeras, Iris; Roberti, Javier; Seijo, Mariana; Suárez, Verónica; Morero, José Luis; Patané, Ana Karina; Kaen, Diego; Lamot, Sebastián; Castro, Mónica; Re, Ricardo; García, Artemio; Vujacich, Patricia; Videla, Alejandro; Recondo, Gonzalo; Fernández-Pazos, Alfonso; Lyons, Gustavo; Paladini, Hugo; ... Journal: BMJ open Issue: Volume 13:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Correlation between PD-L1 expression (clones 28-8 and SP263) and histopathology in lung adenocarcinoma. Issue 6 (June 2020) Authors: García, Alejandro; Recondo, Gonzalo; Greco, Martín; de la Vega, Máximo; Perazzo, Florencia; Recondo, Gonzalo; Avagnina, Alejandra; Denninghoff, Valeria Journal: Heliyon Issue: Volume 6:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations. (May 2022) Authors: Riudavets, Mariona; Auclin, Edouard; Mosteiro, Miguel; Dempsey, Naomi; Majem, Margarita; Lobefaro, Riccardo; López-Castro, Rafael; Bosch-Barrera, Joaquim; Pilotto, Sara; Escalera, Elena; Tagliamento, Marco; Mosquera, Joaquin; Zalcman, Gerard; Aboubakar-Nana, Frank; Ponce, Santiago; Dal Maso, Ales... Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP). (2021) Authors: Cardona, Andrés F.; Ordóñez-Reyes, Camila; Ruiz-Patiño, Alejandro; Garcia-Robledo, Juan Esteban; Barron, Lucia Zatarain; Recondo, Gonzalo; Rojas, Leonardo; Corrales, Luis; Martín, Claudio; Barrón, Feliciano; Sotelo, Carolina; Rodríguez, July; Ricaurte, Luisa; Rolfo, Christian; Ávila, Jenny; Mayor... Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?. Issue 11 (November 2018) Authors: Recondo, Gonzalo; Facchinetti, Francesco; Olaussen, Ken; Besse, Benjamin; Friboulet, Luc Journal: Nature reviews Issue: Volume 15:Issue 11(2018) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S. (17th February 2023) Authors: Blaquier, Juan Bautista; Recondo, Gonzalo Journal: Journal of chemotherapy Issue: Volume 35:Number 2(2023) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗